UBS raised the firm’s price target on Masco to $89 from $82 and keeps a Buy rating on the shares following the Q4 results. UBS believes the company’s portfolio rationalization towards lower ticket, R&R-focused products positions it favorably to manage through the current uncertain macro, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MAS: